FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Buyback Record Date | March 24, 2023 |
Buyback Open Date | March 31, 2023 |
Buyback Closing Date | April 10, 2023 |
Issue Size (Shares) | 0.22 Crores |
Issue Size (Amount) | ₹315.00 Crores |
Buyback Price | ₹1425 per Share |
July 22, 2024 3:30:00 AM
At least 130 employees across various roles and functions will be participating in the buyback The startup added that the buyback ... growth in revenue to INR 243.39 Cr in the financial year 2023-24 ...
Published by : inc42May 2, 2024 2:50:00 PM
Ebitda margin came in at 26 per cent. Ajanta Pharma said its board has approved buyback of up to 10,28,881 fully paid-up shares of face value of Rs 2 each by the company, representing 0.82 per ...
Published by : MSNJuly 19, 2024 1:31:00 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Published by : InvestingJune 25, 2024 10:35:00 AM
Over the last five years, Ajanta Pharma�s ROE has improved by about 400-500bps led by buybacks. Combined, the company has concluded buyback of ?1,100 crore during this period. First-to-market ...
Published by : Business LineJuly 16, 2024 3:30:00 AM
In the third quarter of 2023, TME posted total revenues of $900 million, a 10.8% year-over-year decrease. Tencent cited a decline in revenues from social entertainment services as a reason for the ...
Published by : USA TodayJuly 9, 2024 5:11:00 PM
For example, you might read that �Company XYZ�s board of directors has approved a $500 million buyback authorization, beginning on July 1, 2022, and ending on June 30, 2023.� To be clear ...
Published by : The Motley FoolJuly 9, 2024 3:16:00 PM
Trafigura Group is grappling with a hefty share buyback bill after several years of blockbuster profits, prompting the commodity trading giant to cut the interest it pays on money owed to its ...
Published by : Bloomberg L.P.July 2, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalJune 24, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalJuly 16, 2024 1:33:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarRead Ajanta Pharma Buyback 2023 current news. Find Ajanta Pharma Buyback 2023 subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Ajanta Pharma Limited Buyback grey market premium and Ajanta Pharma Buyback 2023 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|